IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Netherlands

  • ID: 1408490
  • Report
  • Region: Netherlands, Holland
  • 54 Pages
  • IMS Health
1 of 3
The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of pricing and reimbursement specialists to provide industry players and decision makers with a thorough understanding of the rules and regulations governing P&R in international markets.

This report covers key developments in P&R, market access, cost containment, trade margins and healthcare issues.
Note: Product cover images may vary from those shown
2 of 3
1. HEALTHCARE SYSTEM
Facts & Figures
Market Indicators
Provision & Funding
Basic Health Insurance
Supplementary Health Insurance
Long-term Care
Healthcare Funding
Healthcare Providers

2. PRICING
Prescription Drugs
WGP Methodology
WGP Price Revisions
Pricing Agreements
Generic Drugs
Hospital Drugs
Pricing Rules
Price Negotiations and Tendering
Controversy over Hospital Medicines Prices
Joint Purchasing Schemes
Cross-border Procurement
OTC Drugs

3. REIMBURSEMENT
Admission to Reimbursement
Pre-assessment Process
Reimbursement Applications
Assessment
Decision
Appeals
Simplified Reimbursement Process
Managed Entry Schemes
Provisional Reimbursement
Barriers to Access
Reimbursement Categories
Reimbursement Prices
Reference Price System
Preference Policy Scheme
Hospital Reimbursement
Automatic Reimbursement
Denial of Automatic Reimbursement
Reassessments
Managed Entry Schemes
Formularies
DRG System
DRG Add-on Drugs
Specialist Drugs for Hospital Out-patients
Changes in Reimbursement Status
Retail Sector
Hospital Sector
Changes in Reimbursement Prices
Maximum Prices
Reference Prices
Preference Policy
Price Re-negotiations
Impact of Price Controls

4. PHARMACOECONOMICS
Pharmacoeconomic Requirements
Mandatory Requirement
Exemptions
Pharmacoeconomic Guidelines
Proposed QALY Threshold
Hospital Drugs
Orphan Drugs
Provisional Reimbursement

5. PRICE BUILD UP
Wholesalers
Margins
Background
Retail Pharmacies
Pharmacy Remuneration
Discounts
Clawback System
Background
Pharmacy Chains
OTC Sales
E-pharmacy
Supply Shortages
Dispensing Doctors
Sales Tax

6. COST CONTAINMENT
Industry Paybacks
Promotional Costs
Patient Co-payments
Deductible
Other Charges for Prescription Medicines
Prescribing Controls
Treatment Guidelines
Targets
Analysis of Prescribing Habits
Other Prescribing Information
Electronic Prescribing Systems
Managed Entry Schemes
Incentives
Generics
Market
INN Prescribing
Substitution
Preference Policy
Biosimilars
Rx-to-OTC Switches
Switching Process
OTC Market
Parallel Trade

7. FUTURE DEVELOPMENTS
Outlook
Drug Pricing
Medicines Policy Plan
Cross-border Co-operation
Cost-effectiveness Threshold

8. NAMES & ADDRESSES
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll